Mitsubishi Pharma to Establish Pharmaceutical Development Company in Beijing.Tokyo, Japan, May 14, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Mitsubishi Pharma Mitsubishi Pharma Corporation (三菱ウェルファーマ株式会社 announced on May 11 that it will set up a pharmaceutical development subsidiary in Beijing in October. To be capitalized at $1 million, Mitsubishi Pharma R&D (Beijing) (provisional Temporary; not permanent. Tentative, contingent, preliminary. A provisional civil service appointment is a temporary position that fills a vacancy until a test can be properly administered and statutory requirements can be fulfilled to make a permanent appointment. name) will initially employ about 10 people. The Chinese pharmaceutical market is estimated at 1.2 trillion One thousand times one billion, which is 1, followed by 12 zeros, or 10 to the 12th power. See space/time. (mathematics) trillion - In Britain, France, and Germany, 10^18 or a million cubed. In the USA and Canada, 10^12. yen ($10.6 bil), and is expected to grow rapidly. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion